Lily Morris was diagnosed with acute lymphoblastic leukaemia (ALL) in 2022 aged 15. Now 16, she tells us about its impact on her GCSE preparations, and the support she’s received from her school and friends as she transitioned back into full-time education.
Naomi Duxbury’s daughter, Mia, was aged four when diagnosed with B-cell acute lymphoblastic leukaemia in September 2021. Here, she tells us about the importance of working closely with Mia’s school to create a safe, supportive and ‘normal’ learning environment for her.
Charlotte Bowling's daughter, Amelie, was diagnosed with acute lymphoblastic leukaemia (ALL) in June 2019 aged six. Charlotte tells us about the support her daughter and her family received from her school, including an innovative way of ensuring Amelie was involved even when not physically present.
Prof Robert Wynn, Consultant Paediatric Haematologist and Director of Bone Marrow Transplant at Royal Manchester Children’s Hospital, leads the GRANS clinical trial. He tells us how this innovative treatment is showing promising results for children with hard-to-treat leukaemia.
Hannah Longstaff's daughter, Matilda, was diagnosed with acute lymphoblastic leukaemia (ALL) in February 2022, aged three. She tells us how Matilda’s appetite increased after being put on steroids and about the support she has received.
Rudi Keyser's daughter was treated for cancer at Great Ormond Street Hospital (GOSH). He tells us how a decade later, as its Interim Head of Catering, he implemented an innovative app to help young patients to eat.
Claire Crowley’s son, James, was diagnosed with leukaemia in November 2014. She describes the challenges of feeding James while on treatment and the nutrition support he received.
Sarah Cripps’ son, Teddy, was diagnosed with acute myeloid leukaemia (AML) when 18 months old in April 2022. She explains the crucial role diet and nutrition played during Teddy’s treatment
Katy Jones' daughter Eden was three years old when she was diagnosed with leukaemia in July 2017. She explains some of the things her family considered before deciding on entering into a clinical trial.
